Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alps Group Inc (the “ Company ” or “ Alps Group ”), the parent company of Alps Life Sciences Inc. (“ Alps Holdco ”), a fully integrated biotechnology research and healthcare platform specializing in ...
Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a fully integrated ...
Moderna ($MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining ...
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.5% in the afternoon session after the stock ...
Palantir Technologies has been one of the hottest stocks on the market in 2025, rising a stunning 140% as of this writing ...
That's why Visa has few direct competitors of note. And the company still sees a massive worldwide opportunity. The stock looks likely to perform well, and even better than the S&P 500, through the ...
Read why Energy Fuels Inc. (UUUU) is my favorite uranium and rare earths stock pick with strong growth prospects.
This press release corrects and replaces the company’s press release issued today, 10/29, at 4:15 p.m. ET in order to correct a typographical ...
Novartis AG ( NYSE: NVS) M&A Call October 27, 2025 8:00 AM EDT ...
Nassar, N. and Miranda, R. (2025) Cassava Breeding by Unconventional Method Using Periclinal Chimera . Advances in Bioscience ...